Home/Filings/4/0000950170-23-065235
4//SEC Filing

Western Standard LLC 4

Accession 0000950170-23-065235

CIK 0001274792other

Filed

Nov 19, 7:00 PM ET

Accepted

Nov 20, 6:59 PM ET

Size

14.4 KB

Accession

0000950170-23-065235

Insider Transaction Report

Form 4
Period: 2023-11-17
Transactions
  • Purchase

    Common Stock

    2023-11-17$12.50/sh+235$2,9381,659,216 total(indirect: See footnote)
  • Purchase

    Common Stock

    2023-11-17$12.50/sh+65$813459,792 total(indirect: See footnote)
Transactions
  • Purchase

    Common Stock

    2023-11-17$12.50/sh+65$813459,792 total(indirect: See footnote)
  • Purchase

    Common Stock

    2023-11-17$12.50/sh+235$2,9381,659,216 total(indirect: See footnote)
Transactions
  • Purchase

    Common Stock

    2023-11-17$12.50/sh+235$2,9381,659,216 total(indirect: See footnote)
  • Purchase

    Common Stock

    2023-11-17$12.50/sh+65$813459,792 total(indirect: See footnote)
Andersen Eric
DirectorOther
Transactions
  • Purchase

    Common Stock

    2023-11-17$12.50/sh+235$2,9381,659,216 total(indirect: See footnote)
  • Purchase

    Common Stock

    2023-11-17$12.50/sh+65$813459,792 total(indirect: See footnote)
Footnotes (2)
  • [F1]The shares are directly held by WSP. The general partner of the Funds is Western Standard. The managing member of Western Standard and the portfolio manager to the Funds is Mr. Andersen. Each of Western Standard and Mr. Andersen disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares.
  • [F2]The shares are directly held by WSP QP. The general partner of the Funds is Western Standard. The managing member of Western Standard and the portfolio manager to the Funds is Mr. Andersen. Each of Western Standard and Mr. Andersen disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares.

Documents

1 file

Issuer

MERRIMACK PHARMACEUTICALS INC

CIK 0001274792

Entity typeother
IncorporatedCA

Related Parties

1
  • filerCIK 0001517666

Filing Metadata

Form type
4
Filed
Nov 19, 7:00 PM ET
Accepted
Nov 20, 6:59 PM ET
Size
14.4 KB